B-Cell Non-Hodgkin Lymphoma Disease – Global Clinical Trials Review, H1 2020

GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2020" provides an overview of B-Cell Non-Hodgkin Lymphoma Clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

F. Hoffmann-La Roche Ltd

Bristol-Myers Squibb Co

Johnson & Johnson

Novartis AG

AbbVie Inc

Takeda Pharmaceutical Co Ltd

Amgen Inc

AstraZeneca Plc

GlaxoSmithKline Plc

Pfizer Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials 22

Clinical Trials by Phase in E7 Countries 24

Clinical Trials in E7 Countries by Trial Status 25

Clinical Trials by Phase 27

In Progress Trials by Phase 28

Clinical Trials by Trial Status 29

Clinical Trials by End Point Status 31

Subjects Recruited Over a Period of Time 32

Clinical Trials by Sponsor Type 33

Prominent Sponsors 34

Top Companies Participating in B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials 36

Prominent Drugs 38

Latest Clinical Trials News on B-Cell Non-Hodgkin Lymphoma 39

Nov 25, 2019: ArQule to present clinical data for its reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual Meeting 39

Clinical Trial Profile Snapshots 40

Appendix 2332

Abbreviations 2332

Definitions 2332

Research Methodology 2333

Secondary Research 2333

About GlobalData 2334

Contact Us 2334

Disclaimer 2334

Source 2335

List of Tables

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2020* 8

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 10

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020* 12

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2020* 13

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2020* 14

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020* 15

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020* 16

Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2020* 18

B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 19

B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 21

Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2020* 23

B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 24

B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 26

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2020* 27

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2020* 28

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2020* 30

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2020* 31

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 32

B-Cell Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020* 33

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 35

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 37

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 38

List of Figures

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2020* 8

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 9

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020* 12

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020* 13

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2020* 14

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020* 15

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020* 16

Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2020* 17

B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 19

B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 20

Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2020* 22

B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 24

B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 25

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2020* 27

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2020* 28

B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2020* 29

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2020* 31

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 32

B-Cell Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020* 33

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 34

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 36

B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 38

GlobalData Methodology 2333

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports